AKLI
Closed
Akili Inc
0.432
0.000 (0.00%)
Last Update: 02 Jul 2024 16:30:00
Yesterday: 0.432
Day's Range: 0.432 - 0.432
Send
sign up or login to leave a comment!
When Written:
1.6
Akili Interactive Labs, Inc. is a digital medicine company that develops and commercializes clinically-validated cognitive therapeutics. The company was founded in 2011 and is headquartered in Boston, Massachusetts. Akili's products are designed to target specific cognitive functions in the brain, such as attention and working memory, to improve cognitive performance and treat neurological disorders. The company's flagship product, EndeavorRx, is the first and only FDA-cleared prescription video game for children with attention deficit hyperactivity disorder (ADHD). Akili has also developed digital therapeutics for other neurological disorders, including autism spectrum disorder, major depressive disorder, and multiple sclerosis. The company has partnerships with major pharmaceutical companies, such as Pfizer and Shionogi, to develop and commercialize its products.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








